$CRTD
Creatd, Inc. Stock $crtd

$crtd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022073167 Filed on November 16, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$800.0K	$1.023M	$1.405M
YoY Change	-43.07%	-13.29%	726.66%
Cost Of Revenue	$1.340M	$1.405M	$1.139M
YoY Change	17.62%	-0.96%	-407.92%
Gross Profit	-$540.0K	-$381.7K	$266.0K
YoY Change	-302.98%	59.99%	-50.73%
Gross Profit Margin	-67.5%	-37.32%	18.93%
Selling, General & Admin	$4.030M	$4.484M	$11.09M
YoY Change	-63.65%	-29.38%	-20.3%
% of Gross Profit			4167.07%
Research & Development	$270.0K	$235.0K	$275.1K
YoY Change	-1.86%	-27.24%
% of Gross Profit			103.42%
Depreciation & Amortization	$150.0K	$43.55K	$202.5K
YoY Change	-25.93%	-58.08%	406.27%
% of Gross Profit			76.12%
Operating Expenses	$4.290M	$5.595M	$11.36M
YoY Change	-62.24%	-16.15%	179.14%
Operating Profit	-$4.830M	-$5.977M	-$11.10M
YoY Change	-56.47%	-13.52%	214.31%
Interest Expense	-$110.0K	$673.7K	-$52.82K
YoY Change	108.25%	-175.41%	-101.75%
% of Operating Profit
Other Income/Expense, Net	-$2.400M	-$1.885M	-$345.3K
YoY Change	595.13%	-8.2%	-114.45%
Pretax Income	-$10.56M	-$9.526M	-$12.45M
YoY Change	-15.2%	-1.99%	254.8%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$12.38M	-$9.226M	-$12.29M
YoY Change	0.73%	-5.82%	250.16%
Net Earnings / Revenue	-1547.5%	-902.03%	-874.57%
Basic Earnings Per Share		-$0.45
Diluted Earnings Per Share	-$0.42	-$0.45	-$772.0K
COMMON SHARES
Basic Shares Outstanding	29.07M shares	20.36M shares
Diluted Shares Outstanding		21.03M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$710.0K	$439.6K	$3.795M
YoY Change	-81.29%	-70.86%	-52.03%
Cash & Equivalents	$706.2K	$439.5K	$3.795M
Short-Term Investments		$96.00
Other Short-Term Assets	$2.973M	$2.812M	$3.966M
YoY Change	-25.04%	401.18%	19730.62%
Inventory	$405.0K	$879.1K	$106.4K
Prepaid Expenses
Receivables	$239.4K	$222.2K	$337.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.479M	$1.681M	$4.475M
YoY Change	-66.95%	-34.12%	-44.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$212.5K	$249.0K	$102.9K
YoY Change	106.48%	-6.16%	-65.69%
Goodwill	$46.46K	$1.365M	$1.375M
YoY Change	-96.62%
Intangibles	$230.1K	$2.537M	$2.433M
YoY Change	-90.54%
Long-Term Investments	$800.0K	$769.1K	$769.0K
YoY Change	4.04%	-20.63%
Other Assets
YoY Change
Total Long-Term Assets	$3.341M	$7.043M	$4.698M
YoY Change	-28.89%	23.52%	70.22%
TOTAL ASSETS
Total Short-Term Assets	$1.479M	$1.681M	$4.475M
Total Long-Term Assets	$3.341M	$7.043M	$4.698M
Total Assets	$4.820M	$8.724M	$9.173M
YoY Change	-47.46%	5.7%	-14.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.570M	$6.715M	$3.731M
YoY Change	102.92%	146.05%	41.31%
Accrued Expenses	$330.0K	$279.6K	$18.45K
YoY Change	1688.62%	188.77%	-76.94%
Deferred Revenue
YoY Change
Short-Term Debt	$1.684M	$1.787M	$1.343M
YoY Change	25.4%		10.05%
Long-Term Debt Due	$1.646M	$7.821M	$1.438M
YoY Change	14.45%	231.27%	59.76%
Total Short-Term Liabilities	$15.21M	$15.17M	$5.421M
YoY Change	180.53%	181.65%	9.07%
LONG-TERM LIABILITIES
Long-Term Debt	$40.00K	$28.92K	$63.99K
YoY Change	-37.49%	-95.61%	-69.53%
Other Long-Term Liabilities	$2.080M	$2.135M	$0.00
YoY Change		2595.86%	-100.0%
Total Long-Term Liabilities	$2.116M	$2.164M	$63.99K
YoY Change	3206.09%	193.0%	-82.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.21M	$15.17M	$5.421M
Total Long-Term Liabilities	$2.116M	$2.164M	$63.99K
Total Liabilities	$17.32M	$17.34M	$5.485M
YoY Change	215.82%	133.25%	2.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$146.1M	-$133.8M	-$109.6M
YoY Change	33.3%
Common Stock	$39.06K	$24.47K	$16.69K
YoY Change	134.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$78.46K	$76.11K	$62.41K
YoY Change	25.72%
Treasury Stock Shares	93.37K shares	89.46K shares	5.657K shares
Shareholders Equity	-$11.75M	-$9.291M	$1.807M
YoY Change
Total Liabilities & Shareholders Equity	$4.820M	$8.724M	$9.173M
YoY Change	-47.46%	5.7%	-14.9%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$12.38M	-$9.226M	-$12.29M
YoY Change	0.73%	-5.82%	250.16%
Depreciation, Depletion And Amortization	$150.0K	$43.55K	$202.5K
YoY Change	-25.93%	-58.08%	406.27%
Cash From Operating Activities	-$2.950M	-$3.237M	-$4.902M
YoY Change	-39.82%	-29.94%	112.2%
INVESTING ACTIVITIES
Capital Expenditures	$210.0K	-$43.43K	-$29.97K
YoY Change	-800.7%	-15.77%	49.85%
Acquisitions
YoY Change
Other Investing Activities	$1.090M	-$83.52K	$187.0K
YoY Change	482.92%	-84.19%	-255.83%
Cash From Investing Activities	$860.0K	-$127.0K	$157.0K
YoY Change	447.63%	-78.1%	-204.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.350M	2.283M	7.056M
YoY Change	-66.69%	-50.29%	-5.55%
NET CHANGE
Cash From Operating Activities	-2.950M	-3.237M	-4.902M
Cash From Investing Activities	860.0K	-127.0K	157.0K
Cash From Financing Activities	2.350M	2.283M	7.056M
Net Change In Cash	260.0K	-1.081M	2.311M
YoY Change	-88.75%	77.89%	-53.87%
FREE CASH FLOW
Cash From Operating Activities	-$2.950M	-$3.237M	-$4.902M
Capital Expenditures	$210.0K	-$43.43K	-$29.97K
Free Cash Flow	-$3.160M	-$3.194M	-$4.872M
YoY Change	-35.14%	-30.1%	112.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	crtd	Minority Investment In Business MinorityInvestmentInBusiness		usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther		usd
CY2022Q3	crtd	Derivative Expense DerivativeExpense		usd
CY2022Q3	crtd	Gain On Forgiveness Of Debt GainOnForgivenessOfDebt		usd
CY2022Q3	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities		usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.2
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39500
	dei	Entity Registrant Name EntityRegistrantName	Creatd, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0645394
	dei	Entity Address Address Line1 EntityAddressAddressLine1	419 Lafayette Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10003
	dei	City Area Code CityAreaCode	(201)
	dei	Local Phone Number LocalPhoneNumber	258-3770
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29072301	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	439539	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3794734	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	222183	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	337440	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	879050	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	106403	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	96	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	139726	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	236665	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1680594	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4475242	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	248963	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102939	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2536599	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2432841	usd
CY2022Q3	us-gaap	Goodwill Goodwill	1365328	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1374835	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	769136	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	718951	usd
CY2021Q4	crtd	Minority Investment In Business MinorityInvestmentInBusiness	50000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2123171	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18451	usd
CY2022Q3	us-gaap	Assets Assets	8723791	usd
CY2021Q4	us-gaap	Assets Assets	9173259	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6714606	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3730540	usd
CY2022Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	52080	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	6062926	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	159193	usd
CY2022Q3	crtd	Operating Lease Payable Long Term OperatingLeasePayableLongTerm	279593	usd
CY2021Q4	crtd	Operating Lease Payable Long Term OperatingLeasePayableLongTerm	18451	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	1758179	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1278672	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	305555	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	234159	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15172939	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5421015	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	28920	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	63992	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2135393	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2164313	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	63992	usd
CY2022Q3	us-gaap	Liabilities Liabilities	17337252	usd
CY2021Q4	us-gaap	Liabilities Liabilities	5485007	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24469675	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24380218	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16691170	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16685513	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	24470	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16691	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	124667772	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111563618	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	89457	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5657	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	76106	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	62406	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133762800	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109632574	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-143991	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-78272	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-9290655	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1807057	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	677194	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1881195	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8613461	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3688252	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8723791	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9173259	usd
CY2022Q3	us-gaap	Revenues Revenues	1022851	usd
CY2021Q3	us-gaap	Revenues Revenues	1179620	usd
	us-gaap	Revenues Revenues	3997490	usd
	us-gaap	Revenues Revenues	2894390	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1404562	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	1418213	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4771151	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4160743	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-381711	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-238593	usd
	us-gaap	Gross Profit GrossProfit	-773661	usd
	us-gaap	Gross Profit GrossProfit	-1266353	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	234965	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	322946	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	686131	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	708396	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	646520	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1812400	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4016051	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8049579	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	626568	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2151900	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3848578	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5662389	usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	249586	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	257117	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	93791	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3837469	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2385135	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11397989	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5457258	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5595108	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	6672381	usd
	us-gaap	Operating Expenses OperatingExpenses	20205866	usd
	us-gaap	Operating Expenses OperatingExpenses	19971413	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5976819	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6910974	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20979527	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21237766	usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	123710	usd
	us-gaap	Interest Income Other InterestIncomeOther	99	usd
	us-gaap	Interest Income Other InterestIncomeOther	123710	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	673694	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	59859	usd
	us-gaap	Interest Expense InterestExpense	707950	usd
	us-gaap	Interest Expense InterestExpense	319290	usd
CY2022Q3	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	1884679	usd
CY2021Q3	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	2176651	usd
	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	2531687	usd
	crtd	Accretion Of Debt Discount And Issuance Cost AccretionOfDebtDiscountAndIssuanceCost	3028015	usd
	crtd	Derivative Expense DerivativeExpense	100502	usd
CY2021Q3	crtd	Change In Derivative Liability ChangeInDerivativeLiability	-833456	usd
	crtd	Change In Derivative Liability ChangeInDerivativeLiability	3729	usd
	crtd	Change In Derivative Liability ChangeInDerivativeLiability	-1096287	usd
	crtd	Impairment Of Investment ImpairmentOfInvestment	-50000	usd
	crtd	Impairment Of Investment ImpairmentOfInvestment	-62733	usd
	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities	-2867	usd
	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities	92909	usd
CY2022Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-11415	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-11646	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-979738	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	137109	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-832482	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	423118	usd
	crtd	Gain On Forgiveness Of Debt GainOnForgivenessOfDebt	279022	usd
CY2022Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-3549526	usd
CY2021Q3	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-2809147	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-4132804	usd
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-3688068	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9526345	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9720121	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25112331	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24925834	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16413	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16413	usd
CY2022Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-9526345	usd
CY2021Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-9736534	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-25112331	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-24942247	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-299903	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	60477	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-1285661	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	60045	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-9226442	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9797011	usd
	us-gaap	Net Income Loss NetIncomeLoss	-23826670	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25002292	usd
CY2022Q3	crtd	Deemed Dividends DeemedDividends	-221829	usd
	crtd	Deemed Dividends DeemedDividends	-303557	usd
	crtd	Deemed Dividends DeemedDividends	-410750	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9448271	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9797011	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24130227	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25413042	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-9526345	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-9736534	usd
	us-gaap	Profit Loss ProfitLoss	-25112331	usd
	us-gaap	Profit Loss ProfitLoss	-24942247	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-36110	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8436	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-65719	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-16299	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9562455	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9744970	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25178050	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24958546	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.23
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21030188	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13710111	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19669411	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11563150	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1500232	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	568214	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34950	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	122655	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	13700	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	75000	usd
CY2022Q3	crtd	Cash Received For Common Stock And Warrants CashReceivedForCommonStockAndWarrants	725000	usd
CY2022Q3	crtd	Stock Warrants Issued With Note Payable StockWarrantsIssuedWithNotePayable	1012107	usd
CY2022Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-36110	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-9526345	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8613461	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3688252	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3822979	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	141150	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	122655	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	13700	usd
	crtd	Stock Warrants Issued With Note Payable StockWarrantsIssuedWithNotePayable	2907497	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	190000	usd
	crtd	Cash Received For Common Stock And Warrants CashReceivedForCommonStockAndWarrants	5722300	usd
	crtd	Common Stock Issued Upon Conversion Of Notes Payable CommonStockIssuedUponConversionOfNotesPayable	173456	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-65719	usd
	us-gaap	Profit Loss ProfitLoss	-25112331	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8613461	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-452831	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2094810	usd
CY2021Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	4199397	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	893521	usd
CY2021Q3	crtd	Cash Received For Common Stock CashReceivedForCommonStock	248700	usd
CY2021Q3	crtd	Common Stock Issued Upon Conversion Of Notes Payable CommonStockIssuedUponConversionOfNotesPayable	3698504	usd
CY2021Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-8436	usd
CY2021Q3	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	1190000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-9736534	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2127131	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5445196	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5505389	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	226500	usd
	crtd	Stock Issued During Period Value Common Stock Issued To Settle Vendor Liabilities StockIssuedDuringPeriodValueCommonStockIssuedToSettleVendorLiabilities	181385	usd
	crtd	Common Stock Issued Upon Conversion Of Notes Payable CommonStockIssuedUponConversionOfNotesPayable	4015325	usd
	crtd	Exercise Of Warrants To Stock ExerciseOfWarrantsToStock	5472068	usd
	crtd	Cash Received For Common Stock CashReceivedForCommonStock	2462200	usd
	crtd	Cash Received For Preferred Series E And Warrants CashReceivedForPreferredSeriesEAndWarrants	35775	usd
	crtd	Stock Warrants Issued With Note Payable StockWarrantsIssuedWithNotePayable	1601452	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	893522	usd
	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-16299	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1246865	usd
	us-gaap	Profit Loss ProfitLoss	-24942247	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2127131	usd
	us-gaap	Profit Loss ProfitLoss	-25112331	usd
	us-gaap	Profit Loss ProfitLoss	-24942247	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	441943	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	194929	usd
	crtd	Impairment Of Investment ImpairmentOfInvestment	-50000	usd
	crtd	Impairment Of Investment ImpairmentOfInvestment	-62733	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	257117	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	93791	usd
	crtd	Accretion Of Debt Discount And Issuance Costs AccretionOfDebtDiscountAndIssuanceCosts	2531687	usd
	crtd	Accretion Of Debt Discount And Issuance Costs AccretionOfDebtDiscountAndIssuanceCosts	3028015	usd
	crtd	Sharebased Compensation SharebasedCompensation	3848578	usd
	crtd	Sharebased Compensation SharebasedCompensation	5662389	usd
	crtd	Bad Debt Expense BadDebtExpense	124186	usd
	crtd	Gain On Forgiveness Of Debt2 GainOnForgivenessOfDebt2	-832482	usd
	crtd	Gain On Forgiveness Of Debt2 GainOnForgivenessOfDebt2	702140	usd
	crtd	Settlements Of Vendor Liabilities SettlementsOfVendorLiabilities	-2867	usd
	crtd	Settlements Of Vendor Liabilities SettlementsOfVendorLiabilities	92909	usd
	crtd	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	3729	usd
	crtd	Change In Fair Value Of Derivative Liability ChangeInFairValueOfDerivativeLiability	-1096287	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	100502	usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-11646	usd
	crtd	Non Cash Lease Expense NonCashLeaseExpense	44305	usd
	crtd	Non Cash Lease Expense NonCashLeaseExpense	60756	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-123710	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-16413	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-114925	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	471899	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	492128	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	68091	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	481080	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-150980	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	50185	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-107115	usd
	crtd	Increase Decrease In Deferred Revenues IncreaseDecreaseInDeferredRevenues	71396	usd
	crtd	Increase Decrease In Deferred Revenues IncreaseDecreaseInDeferredRevenues	111192	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3805245	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	160434	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	145887	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-61605	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13857189	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15617065	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	213975	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65971	usd
	crtd	Proceeds From Deposits ProceedsFromDeposits	325000	usd
	crtd	Cash Paid For Minority Investment In Business CashPaidForMinorityInvestmentInBusiness	510000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	48878	usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	37135	usd
	crtd	Cash Consideration For Acquisition CashConsiderationForAcquisition	75679	usd
	crtd	Cash Consideration For Acquisition CashConsiderationForAcquisition	412943	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	192795	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	11241	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-494192	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1325155	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5472068	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2174402	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	321229	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2292953	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	403843	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5809755	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3610491	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	337899	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	941880	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13700	usd
	crtd	Purchase Of Treasury Stock And Warrants PurchaseOfTreasuryStockAndWarrants	-5722300	usd
	crtd	Purchase Of Treasury Stock And Warrants PurchaseOfTreasuryStockAndWarrants	-2502200	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11061905	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10560265	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-65719	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-16299	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3355195	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6398254	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3794734	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7906782	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	439539	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1508528	usd
	us-gaap	Interest Paid Net InterestPaidNet	139000	usd
	us-gaap	Interest Paid Net InterestPaidNet	58395	usd
	crtd	Reduction Of Rou Asset Related To Remeasurement Of Lease Liability ReductionOfROUAssetRelatedToRemeasurementOfLeaseLiability	147649	usd
	crtd	Reduction Of Rou Asset Related To Remeasurement Of Lease Liability ReductionOfROUAssetRelatedToRemeasurementOfLeaseLiability	168667	usd
	us-gaap	Stock Issued1 StockIssued1	2907497	usd
	us-gaap	Stock Issued1 StockIssued1	1601452	usd
	crtd	Share Issued For Acquisition ShareIssuedForAcquisition	141150	usd
	crtd	Share Issued For Acquisition ShareIssuedForAcquisition	226500	usd
	crtd	Operating Lease Liability1 OperatingLeaseLiability1	2250648	usd
	crtd	Deferred Offering Cost DeferredOfferingCost	4225	usd
	crtd	Repayment Of Promissory Notes From Australian Rd Credits RepaymentOfPromissoryNotesFromAustralianRDCredits	173455	usd
	crtd	Repayment Of Promissory Notes From Australian Rd Credits RepaymentOfPromissoryNotesFromAustralianRDCredits	4015325	usd
	crtd	Shares Issued For Acquisition SharesIssuedForAcquisition	40994	usd
	crtd	Shares Issued For Acquisition SharesIssuedForAcquisition	893520	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><i><span style="text-decoration:underline">Use of Estimates and Critical Accounting Estimates and Assumptions</span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span> </span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. The Company uses estimates in accounting for, among other items, revenue recognition, allowance for doubtful accounts, stock-based compensation, income tax provisions, excess and obsolete inventory reserve, and impairment of intellectual property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	355509	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	143776	usd
	crtd	Additional Warrant AdditionalWarrant	127801	shares
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	96	usd
CY2022Q3	crtd	Total Assets TotalAssets	96	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	96	usd
	crtd	All Other Expenses AllOtherExpenses	11646	usd
	crtd	All Other Expenses AllOtherExpenses	0	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1035795	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25139	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	103496	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	879050	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	106403	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><i><span style="text-decoration:underline">Concentration of Credit Risk and Other Risks and Uncertainties</span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company provides credit in the normal course of business. The Company maintains allowances for credit losses on factors surrounding the credit risk of specific customers, historical trends, and other information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The Company operates in Australia and holds total assets of $622,445. It is reasonably possible that operations located outside an entity’s home country will be disrupted in the near term.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span> </span></p>
	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount	622445	usd
CY2022Q3	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	673079	usd
CY2021Q3	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	1167480	usd
	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	2752736	usd
CY2022Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	249586	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	257117	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P7Y1M6D
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	415215	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	443236	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	280223	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	260935	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	239934	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	739762	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2379305	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	157294	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2536599	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	94130	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	75069	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1383785	usd
CY2022Q3	crtd	Goodwill Acquired In A Business Combination GoodwillAcquiredInABusinessCombination	6682	usd
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25139	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1365328	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1374835	usd
	crtd	Goodwill Acquired In A Business Combination GoodwillAcquiredInABusinessCombination	15632	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	25139	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1365328	usd
CY2022Q3	crtd	Shares Of Capital Stock SharesOfCapitalStock	120000000	shares
CY2022Q3	us-gaap	Revenues Revenues	1022851	usd
CY2021Q3	us-gaap	Revenues Revenues	1179620	usd
	us-gaap	Revenues Revenues	3997490	usd
	us-gaap	Revenues Revenues	2894390	usd
	crtd	Products And Services Transferred Over Time ProductsAndServicesTransferredOverTime	2843483	usd
CY2022Q3	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	349772	usd
CY2021Q3	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	12140	usd
	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	1244754	usd
	crtd	Products Transferred At A Point In Time ProductsTransferredAtAPointInTime	50907	usd
CY2022Q3	us-gaap	Revenues Revenues	1022851	usd
CY2021Q3	us-gaap	Revenues Revenues	1179620	usd
	us-gaap	Revenues Revenues	3997490	usd
	us-gaap	Revenues Revenues	2894390	usd
	crtd	Management Fee Percentage ManagementFeePercentage	0.20	pure
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.80	pure
	crtd	Fixed Fees Percentage FixedFeesPercentage	0.20	pure
	crtd	Contract Occur Percentage ContractOccurPercentage	1	pure
	crtd	Promotional Discounts Amount PromotionalDiscountsAmount	9.99	usd
	crtd	Free Trials Amount FreeTrialsAmount	99	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	305555	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	234159	usd
	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	159727	usd
CY2022Q3	us-gaap	Deferred Revenue Additions DeferredRevenueAdditions	13512	usd
	crtd	Common Stock Equivalents CommonStockEquivalents	57053504	shares
	crtd	Common Stock Equivalents CommonStockEquivalents	9114632	shares
CY2022Q3	crtd	Designated Of Common Stock Shares DesignatedOfCommonStockShares	100000000	shares
	crtd	Reserve Doubtful Accounts ReserveDoubtfulAccounts	124186	usd
	crtd	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	311133	usd
CY2021	crtd	Allowance For Doubtful Accounts AllowanceForDoubtfulAccounts	186147	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	430519	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	364814	usd
CY2022Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	248963	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	102939	usd
CY2022Q3	us-gaap	Depreciation Depreciation	43546	usd
CY2022Q3	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	78799	usd
CY2021Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	2907	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	717417	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><i><span style="text-decoration:underline">Reclassifications</span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Certain prior year amounts in the condensed consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year’s presentation. These reclassifications did not affect the prior period’s total assets, total liabilities, stockholders’ deficit, net loss or net cash used in operating activities. During the year ended December 31, 2021, we adopted a change in presentation on our condensed consolidated statements of operations and comprehensive loss in order to present a gross profit line, the presentation of which is consistent with our peers. Under the new presentation, we began allocating payroll and related expenses, professional services and creator payouts. Prior periods have been revised to reflect this change in presentation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span> </span></p>
	crtd	Deemed Dividend DeemedDividend	63064	usd
CY2021Q3	us-gaap	Depreciation Depreciation	10047	usd
	us-gaap	Depreciation Depreciation	67951	usd
	crtd	Accumulated Deficit Net Loss AccumulatedDeficitNetLoss	133800000	usd
	crtd	Net Income Loss Amount NetIncomeLossAmount	25100000	usd
	crtd	Net Cash Used In Operating Activities Going Concern NetCashUsedInOperatingActivitiesGoingConcern	13900000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	82834	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	679482	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	467753	usd
CY2021Q3	crtd	Derivative Expense DerivativeExpense		usd
	us-gaap	Depreciation Depreciation	30141	usd
CY2022Q3	crtd	Outstanding Principal Total OutstandingPrincipalTotal	2401509	usd
CY2021Q4	crtd	Outstanding Principal Total OutstandingPrincipalTotal	1358211	usd
	crtd	Less Debt Discount LessDebtDiscount	614410	usd
CY2021	crtd	Less Debt Discount LessDebtDiscount	15547	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	1787099	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	1342664	usd
CY2022Q3	us-gaap	Convertible Debt ConvertibleDebt	1758179	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	1278672	usd
CY2022Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	28920	usd
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	63992	usd
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.001
CY2022Q3	crtd	Designated Of Preferred Stock DesignatedOfPreferredStock	20000000	shares
CY2022Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.001
CY2022Q3	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	130625	usd
	crtd	Accrued But Unpaid AccruedButUnpaid	69000	usd
CY2022Q1	crtd	Gross Proceeds GrossProceeds	2659750	usd
CY2022Q1	crtd	Aggregate Common Stock Shares AggregateCommonStockShares	1519857	shares
CY2022Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	6429427	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	360854	usd
CY2022Q3	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	5648	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	6062926	usd
CY2022Q3	crtd	Aggregate Common Stock Shares AggregateCommonStockShares	4000000	shares
CY2022Q3	crtd	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	4000000	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.2
CY2022Q3	crtd	Stock Issuance Costs StockIssuanceCosts	75000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	83800	shares
CY2022Q3	crtd	Excise Tax On Net Repurchases Percentage ExciseTaxOnNetRepurchasesPercentage	0.01	pure
CY2022Q2	us-gaap	Operating Leases Indemnification Agreements Description OperatingLeasesIndemnificationAgreementsDescription	On April 26, 2022, the Company signed a 7-year lease for approximately 8,000 square feet of office space at 419 Lafayette Street, 6th Floor, New York, NY, 10003.
CY2022Q2	us-gaap	Lease Income LeaseIncome	3502033	usd
CY2022Q3	us-gaap	Related Party Transaction Due From To Related Party Noncurrent RelatedPartyTransactionDueFromToRelatedPartyNoncurrent	421001	usd
	crtd	Shares Of Common Stock SharesOfCommonStock	240571	shares
	crtd	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	240571	shares
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	87275	usd
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	72328	usd
	crtd	Expected Dividend Yield Percentage ExpectedDividendYieldPercentage	0	pure
CY2022Q1	crtd	Warrants To Purchase Common Stock WarrantsToPurchaseCommonStock	1519857	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.75
	crtd	Stock Issuance Costs StockIssuanceCosts	75000	usd
CY2022Q1	crtd	Stock Issued Period For Service StockIssuedPeriodForService	7488	usd
CY2022Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	8364	usd
CY2022Q2	crtd	Restricted Common Stock RestrictedCommonStock	185000	shares
CY2022Q2	crtd	Stock Issued Period For Service StockIssuedPeriodForService	192400	usd
CY2022Q2	crtd	Restricted Common Stock RestrictedCommonStock	50000	shares
CY2022Q2	crtd	Stock Issued Period For Service StockIssuedPeriodForService	37200	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	2405	usd
CY2022Q2	crtd	Stock Issued Period For Service StockIssuedPeriodForService	29387	usd
CY2022Q2	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	24001	usd
CY2022Q3	crtd	Gross Proceeds GrossProceeds	796000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	541021	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.75
	crtd	Weighted Average Remaining Contractual Lifein Years Beginning Balance WeightedAverageRemainingContractualLifeinYearsBeginningBalance	P3Y3M7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1850588	shares
	crtd	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	6.32
	crtd	Share Based Compensation Award Options Weighted Average Remaining Contractual Life Granted ShareBasedCompensationAwardOptionsWeightedAverageRemainingContractualLifeGranted	P6Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	64164	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.06
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2327445	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.63
	crtd	Weighted Average Remaining Contractual Lifein Years Outstanding Ending Balance WeightedAverageRemainingContractualLifeinYearsOutstandingEndingBalance	P4Y3M14D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	608524	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.75
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2902619	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.07
	crtd	Weighted Average Remaining Contractual Lifein Years Beginning Balance WeightedAverageRemainingContractualLifeinYearsBeginningBalance	P4Y8M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1940000	shares
	crtd	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	1.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	434352	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.56
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4408267	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.93
	crtd	Weighted Average Remaining Contractual Lifein Years Outstanding Ending Balance WeightedAverageRemainingContractualLifeinYearsOutstandingEndingBalance	P4Y5M4D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3010101	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M25D
CY2022Q1	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	920000	usd
	crtd	Option Outstanding Exercise Price OptionOutstandingExercisePrice	3.93
	crtd	Option Outstanding Number Outstanding OptionOutstandingNumberOutstanding	4408267	shares
	crtd	Option Outstanding Weighted Average Remaining Contractual Lifein Years OptionOutstandingWeightedAverageRemainingContractualLifeinYears	P4Y5M4D
	crtd	Option Exercisable Weighted Average Exercise Price OptionExercisableWeightedAverageExercisePrice	4.12
	crtd	Option Exercisable Number Exercisable OptionExercisableNumberExercisable	3010101	shares
	crtd	Option Exercisable Weighted Average Remaining Contractual Lifein Years OptionExercisableWeightedAverageRemainingContractualLifeinYears	P4Y3M25D
CY2018Q4	crtd	Grant Options GrantOptions	11667	shares
CY2018Q4	crtd	Fair Value FairValue	57123	usd
CY2022Q3	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	4100729	usd
	crtd	Unvested Employee Options Description UnvestedEmployeeOptionsDescription	As of September 30, 2022, there was $1,283,111 of total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation plans that is expected to be recognized over a weighted average period of approximately 1.21 years.
	crtd	Warrant Holder Shares WarrantHolderShares	1275261	shares
	crtd	Exercise Warrant Shares ExerciseWarrantShares	1438788	shares
	crtd	Proceed From Warrant Exercises ProceedFromWarrantExercises	5472068	usd
CY2022Q3	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	1090908	shares
	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	3067617	usd
	us-gaap	Dividends Cash DividendsCash	410750	usd
CY2021Q2	crtd	Underwriting Agreement UnderwritingAgreement	46667	shares
CY2021Q3	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	480863	usd
	crtd	Additional Warrent AdditionalWarrent	1740948	shares
	crtd	Deemeds Dividend DeemedsDividend	303557	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6150000	shares
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2929303	usd
CY2020Q2	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	799000	usd
CY2020Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	660000	usd
CY2020Q2	us-gaap	Interest Expense Other InterestExpenseOther	139000	usd
CY2022Q3	us-gaap	Operating Leases Indemnification Agreements Description OperatingLeasesIndemnificationAgreementsDescription	On July 28, 2022, the Company signed a 3-year lease for approximately 1,364 square feet of office space at 1674 Meridian Ave.
CY2022Q3	us-gaap	Lease Income LeaseIncome	181299	usd
CY2022Q3	crtd	Impaired Asset ImpairedAsset	101623	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	148446	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5568	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	154015	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	241601	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	154108	usd
	us-gaap	Lease Cost LeaseCost	395709	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	54564	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.125	pure
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	534880	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	541905	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	513507	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	528589	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	544122	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	892399	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3555402	usd
CY2022Q3	crtd	Less Amounts Representing Interest LessAmountsRepresentingInterest	1140416	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2414986	usd
CY2022Q3	crtd	Less Current Operating Lease LessCurrentOperatingLease	279593	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2135393	usd
CY2022Q3	crtd	Rent Expense RentExpense	154015	usd
CY2021Q3	crtd	Rent Expense RentExpense	67397	usd
	crtd	Rent Expense RentExpense	395709	usd
	crtd	Rent Expense RentExpense	121266	usd
CY2021Q1	crtd	Stockholders Equity Requirement StockholdersEquityRequirement	On September 2, 2022, the Company received a letter from the staff of The Nasdaq Capital Market notifying the Company that the Nasdaq Hearings Panel has determined to delist the Company’s common stock from the Exchange, based on the Company’s failure to comply with the listing requirements of Nasdaq Rule 5550(b)(1) as a result of the Company’s shareholder equity deficit for the period ended June 30, 2022, as demonstrated in Company’s Quarterly Report on Form 10-Q filed on August 15, 2022, following the Company having not complied with the market value of listed securities requirement in Nasdaq Rule 5550(b)(2) on March 1, 2022, while the Company was under a Panel Monitor, as had been previously disclosed.
CY2022Q2	us-gaap	Description Of Postemployment Benefits DescriptionOfPostemploymentBenefits	On April 5, 2022, upon the recommendation of the Compensation Committee of the Board, the Board approved employment agreements with, and equity issuances for, (i) Jeremy Frommer, Executive Chairman, who will receive (a) an signing award of $80,000, (b) an annual salary of $420,000; (c) 121,000 options, to vest immediately with a strike price of $1.75, and (d) 50,000 shares of the Company’s restricted common stock; (ii) Laurie Weisberg, Chief Executive Officer, who will receive (a) an annual salary of $475,000; (b) 121,000 options, to vest immediately with a strike price of $1.75, and (c) 50,000 shares of the Company’s restricted common stock; (iii) Justin Maury, Chief Operating Officer & President, who will receive (a) an annual salary of $475,000 (b) 81,000 options, to vest immediately with a strike price of $1.75, and (c) 50,000 shares of the Company’s restricted common stock; and (iv) Chelsea Pullano, Chief Financial Officer, who will receive (a) an annual salary of $250,000; (b) 37,000 options, to vest immediately with a strike price of $1.75, and (c) 35,000 shares of the Company’s restricted common stock (collectively, the “Executive Employment Arrangements”).
CY2022Q3	us-gaap	Temporary Equity Aggregate Amount Of Redemption Requirement TemporaryEquityAggregateAmountOfRedemptionRequirement	475000	usd
CY2022Q1	crtd	Purchase Price Per Share PurchasePricePerShare	1
	crtd	Schedule Of Excess Purchase Price Amounts ScheduleOfExcessPurchasePriceAmounts	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,950</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names & Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,949</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">107,392</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Website</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,949</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">44,747</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">178,987</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">Know-How and Intellectual Property</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">166,655</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">166,655</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Goodwill</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,683</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Trade Names & Trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Know-How and Intellectual Property</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Website</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16,704</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Excess purchase price</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">66,818</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	5069181	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26428192	usd
	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-2.23
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11845229	shares
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	4683843	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24217030	usd
	us-gaap	Basic Earnings Per Share Pro Forma BasicEarningsPerShareProForma	-1.23
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	19726987	shares
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	222183	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	139726	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	769136	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	2536599	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	1365328	usd
CY2022Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	879050	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2811769	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	8723791	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6714606	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1787099	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	305555	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8529992	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	17337252	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	337440	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	236665	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	718951	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	2432841	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	1374835	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	106403	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3966124	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	9173259	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	3730540	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1342664	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	234159	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	177644	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	5485007	usd
CY2022Q3	us-gaap	Revenues Revenues	1022851	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1404562	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	-381711	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	234965	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	646520	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	626568	usd
CY2022Q3	crtd	General And Administrative GeneralAndAdministrative	4087055	usd
CY2022Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	157996	usd
CY2022Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	249586	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5595108	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	673694	usd
CY2022Q3	crtd	All Other Expense AllOtherExpense	2875832	usd
CY2022Q3	crtd	Other Expenses Net OtherExpensesNet	-3549526	usd
CY2022Q3	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-9526345	usd
CY2021Q3	us-gaap	Revenues Revenues	1179620	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	1418213	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-238593	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	322946	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1812400	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2151900	usd
CY2021Q3	crtd	General And Administrative GeneralAndAdministrative	2385135	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6672381	usd
CY2021Q3	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-9720121	usd
	us-gaap	Revenues Revenues	3997490	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4771151	usd
	us-gaap	Gross Profit GrossProfit	-773661	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	686131	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4016051	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3848578	usd
	crtd	General And Administrative GeneralAndAdministrative	10956046	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	441943	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	257117	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	20205866	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	707950	usd
	crtd	All Other Expense AllOtherExpense	3424854	usd
	crtd	Other Expenses Net OtherExpensesNet	-4132804	usd
	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-25112331	usd
	us-gaap	Revenues Revenues	2894390	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4160743	usd
	us-gaap	Gross Profit GrossProfit	-1266353	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	708396	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8049579	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5662389	usd
	crtd	General And Administrative GeneralAndAdministrative	5551049	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	19971413	usd
	crtd	Loss Before Income Tax Provision And Equity In Net Loss From Unconsolidated Investments LossBeforeIncomeTaxProvisionAndEquityInNetLossFromUnconsolidatedInvestments	-24925834	usd
CY2022Q3	crtd	Warrant Exercisable WarrantExercisable	4227114	shares
	crtd	Forfeitures Warrants Share ForfeituresWarrantsShare	4227114	shares
	crtd	Gross Proceeds GrossProceeds	354994	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	750000	usd
	us-gaap	Payments For Securities Purchased Under Agreements To Resell PaymentsForSecuritiesPurchasedUnderAgreementsToResell	750000	usd
	crtd	Gross Proceeds Percentage GrossProceedsPercentage	0.50	pure
	crtd	Warrants Description WarrantsDescription	The Replacement Warrants reflect a reduction in the number of Series C and Series D Warrants from 1,550,000 in each class to 1,536,607 in each class and a reduction in the number of Series E and Series F Warrants from 1,075,000 in each class to 807,143 in each class, and the initial exercise date for the Replacement Warrants are unchanged from the date as set forth in the respective exchanged Series C, Series D, Series E or Series F Warrant.
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent		usd
	crtd	Derivative Expense DerivativeExpense		usd
CY2021Q3	crtd	Settlement Of Vendor Liabilities SettlementOfVendorLiabilities		usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss		usd
CY2021Q3	crtd	Gain On Forgiveness Of Debt GainOnForgivenessOfDebt		usd
	crtd	Gain On Forgiveness Of Debt GainOnForgivenessOfDebt		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	crtd	Deemed Dividends DeemedDividends		usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11563150	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13710111	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19669411	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21030188	shares
CY2022Q3	us-gaap	Dividends Dividends		usd
CY2021Q3	crtd	Conversion Of Preferred Series E To Stock ConversionOfPreferredSeriesEToStock		usd
	crtd	Conversion Of Preferred Series E To Stock ConversionOfPreferredSeriesEToStock		usd
	us-gaap	Dividends Dividends		usd
	crtd	Bad Debt Expense BadDebtExpense		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss		usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments		usd
	crtd	Proceeds From Deposits ProceedsFromDeposits		usd
	crtd	Cash Paid For Minority Investment In Business CashPaidForMinorityInvestmentInBusiness		usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments		usd
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	crtd	Operating Lease Liability1 OperatingLeaseLiability1		usd
	crtd	Deferred Offering Cost DeferredOfferingCost		usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2022Q3	crtd	Debt Issuance Costs DebtIssuanceCosts		usd
CY2021Q4	crtd	Debt Issuance Costs DebtIssuanceCosts		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	crtd	Share Based Compensation Award Options Weighted Average Remaining Contractual Life Granted ShareBasedCompensationAwardOptionsWeightedAverageRemainingContractualLifeGranted
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	crtd	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
	crtd	Weighted Average Remaining Contractual Lifein Years Forfeited Cancelled WeightedAverageRemainingContractualLifeinYearsForfeitedCancelled
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001357671

Files In Submission

Name	View Source	Status
0001213900-22-073167-index-headers.html	Edgar Link	pending
0001213900-22-073167-index.html	Edgar Link	pending
0001213900-22-073167.txt	Edgar Link	pending
0001213900-22-073167-xbrl.zip	Edgar Link	pending
crtd-20220930.xsd	Edgar Link	pending
f10q0922ex31-1_creatdinc.htm	Edgar Link	pending
f10q0922ex31-2_creatdinc.htm	Edgar Link	pending
f10q0922ex32-1_creatdinc.htm	Edgar Link	pending
f10q0922ex32-2_creatdinc.htm	Edgar Link	pending
f10q0922_creatdinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
crtd-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crtd-20220930_lab.xml	Edgar Link	unprocessable
crtd-20220930_pre.xml	Edgar Link	unprocessable
f10q0922_creatdinc_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crtd-20220930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRTD
Creatd, Inc. Stock $crtd

2022 Q4 Form 10-Q Financial Statement

#000121390022073167 Filed on November 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTD Creatd, Inc. Stock $crtd

2022 Q4 Form 10-Q Financial Statement

#000121390022073167 Filed on November 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRTD
Creatd, Inc. Stock $crtd